CMTM4 can negatively regulate PAK4 to inhibit the PI3K/AKT pathway, which in turn inhibits cell proliferation, and high CMTM4 expression can inhibit pancreatic cancer (Li et al., 2020a). This evidence concerns the gene CMTM4 and familial pancreatic carcinoma.